What is Ihuman Inc's earnings per share (EPS)?

Ihuman Inc (IH) reported diluted earnings per share of $0.05 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ihuman Inc Financials

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Ihuman Inc (IH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI IH FY2024 2026-04-24

Stable gross margins and a cash-heavy balance sheet mask a business whose latest slowdown hit cash conversion hardest.

Since FY2022, operating cash flow has fallen from $27.3M to $8.0M. Yet FY2024 still showed net income of $13.5M on $126.3M of revenue, so the latest deterioration looks less like the model lost gross profitability and more like earnings turned into cash much less efficiently than they did in the prior two years.

With gross margin still at 69.4% and capital spending only $1.0M, this does not read like a business that needs heavy physical reinvestment just to stand still. The pressure in FY2024 came more from fixed-cost absorption: revenue softened, while the operating cost base stayed large enough that margin compressed even though underlying unit economics remained relatively high.

The company still carries a net-cash posture, with $153.9M of cash against $62.9M of total liabilities. That liquidity helps explain why it could keep paying dividends and repurchasing shares even as free cash flow fell to $7.0M, meaning capital returns were supported by an accumulated cash buffer rather than by the year’s cash generation alone.

Financial Health Signals

Financial Profile 51/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Ihuman Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Ihuman Inc has an operating margin of 8.3%, meaning the company retains $8 of operating profit per $100 of revenue. This results in a moderate score of 44/100, indicating healthy but not exceptional operating efficiency. This is up from 7.8% the prior year.

Growth

Ihuman Inc's revenue declined 8.7% year-over-year, from $126.3M to $115.4M. This contraction results in a growth score of 16/100.

Leverage

Ihuman Inc carries a low D/E ratio of 0.38, meaning only $0.38 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 94/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

With a current ratio of 3.57, Ihuman Inc holds $3.57 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 70/100.

Cash Flow

Ihuman Inc has a free cash flow margin of 5.8%, earning a moderate score of 44/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Ihuman Inc's ROE of 9.6% shows moderate profitability relative to equity, earning a score of 37/100. This is down from 10.3% the prior year.

Altman Z-Score Grey Zone

2.56

Ihuman Inc scores 2.56, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Neutral

4/9

Ihuman Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

0.54x

For every $1 of reported earnings, Ihuman Inc generates $0.54 in operating cash flow ($7.3M OCF vs $13.6M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$115.4M

YoY-8.7%

5Y CAGR+7.2%

Ihuman Inc generated $115.4M in revenue in fiscal year 2025. This represents a decrease of 8.7% from the prior year.

EBITDA

$10.7M

YoY-9.1%

Ihuman Inc's EBITDA was $10.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 9.1% from the prior year.

Net Income

$13.6M

YoY+1.0%

Ihuman Inc reported $13.6M in net income in fiscal year 2025. This represents an increase of 1.0% from the prior year.

EPS (Diluted)

$0.05

YoY+0.0%

Ihuman Inc earned $0.05 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$6.6M

YoY-5.2%

5Y CAGR-26.9%

Ihuman Inc generated $6.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 5.2% from the prior year.

Cash & Debt

$164.6M

YoY+7.0%

5Y CAGR+4.5%

Ihuman Inc held $164.6M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.02

Ihuman Inc paid $0.02 per share in dividends in fiscal year 2025.

Shares Outstanding

256M

Ihuman Inc had 256M shares outstanding in fiscal year 2025.

Margins & Returns

Gross Margin

67.9%

YoY-1.6pp

5Y CAGR-0.8pp

Ihuman Inc's gross margin was 67.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.6 percentage points from the prior year.

Operating Margin

8.3%

YoY+0.5pp

5Y CAGR+16.6pp

Ihuman Inc's operating margin was 8.3% in fiscal year 2025, reflecting core business profitability. This is up 0.5 percentage points from the prior year.

Net Margin

11.8%

YoY+1.1pp

5Y CAGR+18.9pp

Ihuman Inc's net profit margin was 11.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.1 percentage points from the prior year.

Return on Equity

9.6%

YoY-0.7pp

5Y CAGR+15.4pp

Ihuman Inc's ROE was 9.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.7 percentage points from the prior year.

Capital Allocation

R&D Spending

$29.8M

YoY-12.2%

5Y CAGR-0.5%

Ihuman Inc invested $29.8M in research and development in fiscal year 2025. This represents a decrease of 12.2% from the prior year.

Share Buybacks

$2.5M

YoY+86.4%

Ihuman Inc spent $2.5M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 86.4% from the prior year.

Capital Expenditures

$701K

YoY-31.3%

5Y CAGR-22.1%

Ihuman Inc invested $701K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 31.3% from the prior year.

IH Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$115.4M-8.7%	$126.3M-11.9%	$143.4M+0.4%	$142.9M-3.6%	$148.2M+81.9%	$81.5M
Cost of Revenue	$37.1M-4.0%	$38.6M-7.6%	$41.8M-2.0%	$42.7M-4.3%	$44.6M	N/A
Gross Profit	$78.3M-10.7%	$87.7M-13.7%	$101.6M+1.4%	$100.2M-3.3%	$103.7M+85.1%	$56.0M
R&D Expenses	$29.8M-12.2%	$33.9M-6.4%	$36.3M-20.2%	$45.5M-30.3%	$65.2M+113.2%	$30.6M
SG&A Expenses	$13.1M-3.8%	$13.6M-7.5%	$14.7M-7.2%	$15.8M+3.5%	$15.3M-13.0%	$17.6M
Operating Income	$9.5M-3.1%	$9.9M-56.3%	$22.5M+39.2%	$16.2M+290.0%	-$8.5M-25.0%	-$6.8M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$913K-44.5%	$1.6M-46.1%	$3.1M-8.3%	$3.3M+14569.6%	-$23K-132.4%	$71K
Net Income	$13.6M+1.0%	$13.5M-47.0%	$25.5M+60.0%	$15.9M+373.9%	-$5.8M-1.3%	-$5.7M
EPS (Diluted)	$0.050.0%	$0.05-44.4%	$0.09+50.0%	$0.06+400.0%	$-0.02	N/A

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	N/A

IH Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$195.7M+0.6%	$194.5M-4.8%	$204.3M+5.7%	$193.3M+11.9%	$172.8M+7.7%	$160.5M
Current Assets	$185.7M+1.5%	$183.0M-6.0%	$194.7M+7.1%	$181.8M+14.1%	$159.3M+1.8%	$156.5M
Cash & Equivalents	$164.6M+7.0%	$153.9M-10.0%	$171.0M+12.3%	$152.2M+13.4%	$134.2M+1.6%	$132.1M
Inventory	$3.1M-4.9%	$3.2M+38.2%	$2.3M-16.1%	$2.8M-37.0%	$4.4M+70.2%	$2.6M
Accounts Receivable	$6.7M-5.6%	$7.1M-16.8%	$8.6M-25.8%	$11.5M+31.1%	$8.8M-26.3%	$11.9M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$53.4M-15.1%	$62.9M-9.4%	$69.4M-15.1%	$81.8M+5.8%	$77.3M+24.7%	$62.0M
Current Liabilities	$52.0M-15.1%	$61.3M-11.3%	$69.1M-15.0%	$81.3M+7.3%	$75.8M+23.9%	$61.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$142.3M+8.1%	$131.6M-2.4%	$134.9M+20.9%	$111.6M+16.9%	$95.5M-3.1%	$98.5M
Retained Earnings	$7.6M+232.0%	-$5.8M+70.8%	-$19.8M+57.5%	-$46.6M+29.9%	-$66.4M-12.2%	-$59.2M

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20
Total Assets	$195.7M+0.6%	$194.5M-4.8%	$204.3M+5.7%	$193.3M+11.9%	$172.8M+7.7%	$160.5M
Current Assets	$185.7M+1.5%	$183.0M-6.0%	$194.7M+7.1%	$181.8M+14.1%	$159.3M+1.8%	$156.5M
Cash & Equivalents	$164.6M+7.0%	$153.9M-10.0%	$171.0M+12.3%	$152.2M+13.4%	$134.2M+1.6%	$132.1M
Inventory	$3.1M-4.9%	$3.2M+38.2%	$2.3M-16.1%	$2.8M-37.0%	$4.4M+70.2%	$2.6M
Accounts Receivable	$6.7M-5.6%	$7.1M-16.8%	$8.6M-25.8%	$11.5M+31.1%	$8.8M-26.3%	$11.9M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$53.4M-15.1%	$62.9M-9.4%	$69.4M-15.1%	$81.8M+5.8%	$77.3M+24.7%	$62.0M
Current Liabilities	$52.0M-15.1%	$61.3M-11.3%	$69.1M-15.0%	$81.3M+7.3%	$75.8M+23.9%	$61.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$142.3M+8.1%	$131.6M-2.4%	$134.9M+20.9%	$111.6M+16.9%	$95.5M-3.1%	$98.5M
Retained Earnings	$7.6M+232.0%	-$5.8M+70.8%	-$19.8M+57.5%	-$46.6M+29.9%	-$66.4M-12.2%	-$59.2M

IH Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$7.3M-8.5%	$8.0M-66.9%	$24.2M-11.3%	$27.3M+355.7%	$6.0M-82.5%	$34.2M
Capital Expenditures	$701K-31.3%	$1.0M+11.2%	$917K-4.0%	$955K-81.1%	$5.1M+107.7%	$2.4M
Free Cash Flow	$6.6M-5.2%	$7.0M-70.0%	$23.3M-11.5%	$26.4M+2735.4%	$930K-97.1%	$31.7M
Investing Cash Flow	$5.8M+180.2%	-$7.2M-688.2%	-$917K+80.7%	-$4.8M+5.0%	-$5.0M-105.6%	-$2.4M
Financing Cash Flow	-$8.0M+42.8%	-$14.0M-952.8%	-$1.3M-31.9%	-$1.0M-1676.6%	$64K-99.9%	$87.7M
Dividends Paid	$5.6M+15.7%	$4.8M	N/A	N/A	N/A	N/A
Share Buybacks	$2.5M+86.4%	$1.3M-1.9%	$1.3M+33.2%	$1.0M+3780.8%	$26K	N/A

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

IH Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	67.9%-1.6pp	69.4%-1.4pp	70.8%+0.7pp	70.1%+0.2pp	69.9%+1.2pp	68.7%
Operating Margin	8.3%+0.5pp	7.8%-7.9pp	15.7%+4.4pp	11.3%+17.1pp	-5.7%+2.6pp	-8.4%
Net Margin	11.8%+1.1pp	10.7%-7.1pp	17.8%+6.6pp	11.1%+15.1pp	-3.9%+3.1pp	-7.0%
Return on Equity	9.6%-0.7pp	10.3%-8.6pp	18.9%+4.6pp	14.3%+20.4pp	-6.1%-0.3pp	-5.8%
Return on Assets	7.0%+0.0pp	6.9%-5.5pp	12.5%+4.2pp	8.2%+11.6pp	-3.4%+0.2pp	-3.6%
Current Ratio	3.57+0.6	2.98+0.2	2.82+0.6	2.23+0.1	2.10-0.5	2.56
Debt-to-Equity	0.38-0.1	0.48-0.0	0.51-0.2	0.73-0.1	0.81+0.2	0.63
FCF Margin	5.8%+0.2pp	5.5%-10.7pp	16.3%-2.2pp	18.4%+17.8pp	0.6%-38.3pp	38.9%

Metric	Q4'25	Q4'24	Q4'23	Q4'22	Q4'21	Q4'20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	3.57+0.6	2.98+0.2	2.82+0.6	2.23+0.1	2.10-0.5	2.56
Debt-to-Equity	0.38-0.1	0.48-0.0	0.51-0.2	0.73-0.1	0.81+0.2	0.63
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Legacy Education Inc LGCY

$144.5M

$160.1M

$40.1M

$63.2M

$252.7M

Frequently Asked Questions

What is Ihuman Inc's annual revenue?

Ihuman Inc (IH) reported $115.4M in total revenue for fiscal year 2025. This represents a -8.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ihuman Inc's revenue growing?

Ihuman Inc (IH) revenue declined by 8.7% year-over-year, from $126.3M to $115.4M in fiscal year 2025.

Is Ihuman Inc profitable?

Yes, Ihuman Inc (IH) reported a net income of $13.6M in fiscal year 2025, with a net profit margin of 11.8%.

What is Ihuman Inc's EBITDA?

Ihuman Inc (IH) had EBITDA of $10.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Ihuman Inc's gross margin?

Ihuman Inc (IH) had a gross margin of 67.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Ihuman Inc's operating margin?

Ihuman Inc (IH) had an operating margin of 8.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Ihuman Inc's net profit margin?

Ihuman Inc (IH) had a net profit margin of 11.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Ihuman Inc pay dividends?

Yes, Ihuman Inc (IH) paid $0.02 per share in dividends during fiscal year 2025.

What is Ihuman Inc's return on equity (ROE)?

Ihuman Inc (IH) has a return on equity of 9.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Ihuman Inc's free cash flow?

Ihuman Inc (IH) generated $6.6M in free cash flow during fiscal year 2025. This represents a -5.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Ihuman Inc's operating cash flow?

Ihuman Inc (IH) generated $7.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Ihuman Inc's total assets?

Ihuman Inc (IH) had $195.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Ihuman Inc's capital expenditures?

Ihuman Inc (IH) invested $701K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Ihuman Inc spend on research and development?

Ihuman Inc (IH) invested $29.8M in research and development during fiscal year 2025.

Does Ihuman Inc buy back shares?

Yes, Ihuman Inc (IH) spent $2.5M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Ihuman Inc have outstanding?

Ihuman Inc (IH) had 256M shares outstanding as of fiscal year 2025.

What is Ihuman Inc's current ratio?

Ihuman Inc (IH) had a current ratio of 3.57 as of fiscal year 2025, which is generally considered healthy.

What is Ihuman Inc's debt-to-equity ratio?

Ihuman Inc (IH) had a debt-to-equity ratio of 0.38 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Ihuman Inc's return on assets (ROA)?

Ihuman Inc (IH) had a return on assets of 7.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Ihuman Inc's Altman Z-Score?

Ihuman Inc (IH) has an Altman Z-Score of 2.56, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Ihuman Inc's Piotroski F-Score?

Ihuman Inc (IH) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Ihuman Inc's earnings high quality?

Ihuman Inc (IH) has an earnings quality ratio of 0.54x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Ihuman Inc?

Ihuman Inc (IH) scores 51 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.